Open AccessJournal Article
Pulmonary surfactants and their role in pathophysiology of lung disorders
TLDR
The biochemical, physiological, developmental and clinical aspects of pulmonary surfactant are presented in this article to understand the pathophysiological mechanisms of these diseases.Abstract:
Surfactant is an agent that decreases the surface tension between two media. The surface tension between gaseous-aqueous interphase in the lungs is decreased by the presence of a thin layer of fluid known as pulmonary surfactant. The pulmonary surfactant is produced by the alveolar type-II (AT-II) cells of the lungs. It is essential for efficient exchange of gases and for maintaining the structural integrity of alveoli. Surfactant is a secretory product, composed of lipids and proteins. Phosphatidylcholine and phosphatidylglycerol are the major lipid constituents and SP-A, SP-B, SP-C, SP-D are four types of surfactant associated proteins. The lipid and protein components are synthesized separately and are packaged into the lamellar bodies in the AT-II cells. Lamellar bodies are the main organelle for the synthesis and metabolism of surfactants. The synthesis, secretion and recycling of the surfactant lipids and proteins is regulated by complex genetic and metabolic mechanisms. The lipid-protein interaction is very important for the structural organization of surfactant monolayer and its functioning. Alterations in surfactant homeostasis or biophysical properties can result in surfactant insufficiency which may be responsible for diseases like respiratory distress syndrome, lung proteinosis, interstitial lung diseases and chronic lung diseases. The biochemical, physiological, developmental and clinical aspects of pulmonary surfactant are presented in this article to understand the pathophysiological mechanisms of these diseases.read more
Citations
More filters
Journal ArticleDOI
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes.
TL;DR: The complex interplay between pulmonary processes is highlighted and how various sequential or parallel pulmonary processes should be considered in order to comprehend the pulmonary fate of inhaled drugs are described.
Journal ArticleDOI
Effect of particle agglomeration in nanotoxicology.
TL;DR: The topic of this review is the role of agglomeration on toxicity, including the fate of nanomaterials after their release and the biological effects they may induce, and ENP uptake and intracellular distribution.
Journal ArticleDOI
The impact of vitamin D on fetal and neonatal lung maturation. A systematic review
TL;DR: The hypothesis of hypovitaminosis D as a frequent, modifiable risk factor of RDS and BPD should be tested in randomized controlled trials on pregnant women, those with threatening preterm delivery, or in the preterm neonates.
Journal ArticleDOI
Myc Expression Drives Aberrant Lipid Metabolism in Lung Cancer
Zoe Hall,Zsuzsanna Ament,Catherine H. Wilson,Deborah L. Burkhart,Tom Ashmore,Albert Koulman,Trevor D. Littlewood,Gerard I. Evan,Julian L. Griffin,Julian L. Griffin +9 more
TL;DR: A transgenic mouse model of KRAS-driven lung adenocarcinoma that affords reversible activation of MYC is described, showing how MYC drives the production of specific eicosanoids critical for lung cancer cell survival and proliferation, with possible implications for the use of COX and LOX pathway inhibitors for lungcancer therapy.
Journal ArticleDOI
Evaluation of the Transwell System for Characterization of Dissolution Behavior of Inhalation Drugs: Effects of Membrane and Surfactant.
Marc Rohrschneider,Sharvari Bhagwat,Raphael Krampe,Victoria Michler,Jörg Breitkreutz,Günther Hochhaus +5 more
TL;DR: The optimized procedure, using membranes with increased permeability and surfactant containing dissolution medium, represents a good starting point to further evaluate in vitro/in vivo correlations.
References
More filters
Journal ArticleDOI
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.
V. Marco Ranieri,Peter M. Suter,Cosimo Tortorella,Renato De Tullio,Jean-Michel Dayer,A. Brienza,Francesco Bruno,Arthur S. Slutsky +7 more
TL;DR: Mechanical ventilation can induce a cytokine response that may be attenuated by a strategy to minimize overdistention and recruitment/derecruitment of the lung, and these physiological improvements are associated with improvements in clinical end points.
Journal ArticleDOI
Surface properties in relation to atelectasis and hyaline membrane disease.
Mary Ellen Avery,Jere Mead +1 more
TL;DR: Evidence is presented that the material responsible for such a low surface tension is absent in the lungs of infants under 1,100-1,200 gm.
Journal ArticleDOI
Basal cells as stem cells of the mouse trachea and human airway epithelium
Jason R. Rock,Mark W. Onaitis,Emma L. Rawlins,Yun Lu,Cheryl P. Clark,Yan Xue,Scott H. Randell,Brigid L.M. Hogan +7 more
TL;DR: The pseudostratified epithelium of the mouse trachea and human airways contains a population of basal cells expressing Trp-63 and cytokeratins 5, which generate differentiated cells during postnatal growth and in the adult during both steady state and epithelial repair.
Journal ArticleDOI
Alveolar epithelial type II cell: defender of the alveolus revisited
TL;DR: Controversy about the character of hyperplastic AE2 cells, reported to synthesise profibrotic factors, proscribes drawing a definite conclusion today.
Journal ArticleDOI
Pulmonary Alveolar Proteinosis
TL;DR: In acquired pulmonary alveolar proteinosis, lipids and proteins accumulate within the alveoli becauseAlveolar macrophages cannot catabolize surfactants.
Related Papers (5)
An overview of pulmonary surfactant in the neonate: Genetics, metabolism, and the role of surfactant in health and disease
Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films.
Elisa Parra,Jesús Pérez-Gil +1 more